In the same post hoc analysis, the improvements with 150 mg (20.0% of the sample) did not reach statistical significance [ 36 ].
← all excerpts
Efficacy and Safety of Peripherally Acting μ-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review.
1
—
—